(Q37524046)

20 August 2017

1 reference

title

Vaccination approaches against Trypanosoma cruzi infection (English)

1 reference

20 August 2017

0 references

Emilio Luis Malchiodi

series ordinal

3

0 references

author name string

Silvia Inés Cazorla

series ordinal

1

1 reference

PubMed ID

19538117

20 August 2017

Fernanda María Frank

series ordinal

2

1 reference

20 August 2017

1 July 2009

1 reference

Expert Review of Vaccines

20 August 2017

1 reference

20 August 2017

8

1 reference

20 August 2017

7

1 reference

20 August 2017

921-935

1 reference

A 9,000-year record of Chagas' disease

20 August 2017

1 reference

Trypanosoma cruzi infection by oral route: how the interplay between parasite and host components modulates infectivity

21 January 2018

1 reference

The challenges of Chagas Disease-- grim outlook or glimmer of hope

21 January 2018

1 reference

Trypanocidal and leishmanicidal activities of sesquiterpene lactones from Ambrosia tenuifolia Sprengel (Asteraceae).

21 January 2018

1 reference

An insight on targets and patented drugs for chemotherapy of Chagas disease.

21 January 2018

1 reference

Immune system recognition of Trypanosoma cruzi

21 January 2018

1 reference

Adaptive immune features of natural killer cells

21 January 2018

1 reference

Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi

21 January 2018

1 reference

NK cells contribute to the control of Trypanosoma cruzi infection by killing free parasites by perforin-independent mechanisms

21 January 2018

1 reference

NK cell activation and protection occur independently of natural killer T cells during Trypanosoma cruzi infection

21 January 2018

1 reference

Human defensin alpha-1 causes Trypanosoma cruzi membrane pore formation and induces DNA fragmentation, which leads to trypanosome destruction

21 January 2018

1 reference

Trypanosoma cruzi infection from the view of CD8+ T cell immunity--an infection model for developing T cell vaccine

21 January 2018

1 reference

Type 1 immunity provides both optimal mucosal and systemic protection against a mucosally invasive, intracellular pathogen.

21 January 2018

1 reference

Distinct kinetics of effector CD8+ cytotoxic T cells after infection with Trypanosoma cruzi in naive or vaccinated mice.

21 January 2018

1 reference

Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice

21 January 2018

1 reference

Stable CD8+ T cell memory during persistent Trypanosoma cruzi infection

21 January 2018

1 reference

Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease

21 January 2018

1 reference

CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes

21 January 2018

1 reference

Critical contribution of immunoproteasomes in the induction of protective immunity against Trypanosoma cruzi in mice vaccinated with a plasmid encoding a CTL epitope fused to green fluorescence protein.

21 January 2018

1 reference

Current status and future prospects for a vaccine against American trypanosomiasis

21 January 2018

1 reference

Some kinetic properties of a cysteine proteinase (cruzipain) from Trypanosoma cruzi

21 January 2018

1 reference

Use of a purified Trypanosoma cruzi antigen and CpG oligodeoxynucleotides for immunoprotection against a lethal challenge with trypomastigotes

21 January 2018

1 reference

Prime-boost immunization with cruzipain co-administered with MALP-2 triggers a protective immune response able to decrease parasite burden and tissue injury in an experimental Trypanosoma cruzi infection model

21 January 2018

1 reference

Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi

21 January 2018

1 reference

Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection

21 January 2018

1 reference

Long-term protective immunity induced against Trypanosoma cruzi infection after vaccination with recombinant adenoviruses encoding amastigote surface protein-2 and trans-sialidase

21 January 2018

1 reference

Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate

21 January 2018

1 reference

Immunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infection

21 January 2018

1 reference

CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2.

21 January 2018

1 reference

Novel protective antigens expressed by Trypanosoma cruzi amastigotes provide immunity to mice highly susceptible to Chagas' disease

21 January 2018

1 reference

The genetic immunization with paraflagellar rod protein-2 fused to the HSP70 confers protection against late Trypanosoma cruzi infection

21 January 2018

1 reference

Immunological and pathological responses in BALB/c mice induced by genetic administration of Tc 13 Tul antigen of Trypanosoma cruzi.

21 January 2018

1 reference

Utility of the Trypanosoma cruzi sequence database for identification of potential vaccine candidates by in silico and in vitro screening

21 January 2018

1 reference

Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice

21 January 2018

1 reference

DNA Vaccines against Protozoan Parasites: Advances and Challenges

21 January 2018

1 reference

Identification of novel vaccine candidates for Chagas' disease by immunization with sequential fractions of a trypomastigote cDNA expression library

21 January 2018

1 reference

Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.

21 January 2018

1 reference

Vaccination with Trypanosoma rangeli reduces the infectiousness of dogs experimentally infected with Trypanosoma cruzi.

21 January 2018

1 reference

Alternative trans-splicing of the Trypanosoma cruzi LYT1 gene transcript results in compartmental and functional switch for the encoded protein.

21 January 2018

1 reference

Impairment of infectivity and immunoprotective effect of a LYT1 null mutant of Trypanosoma cruzi

21 January 2018

1 reference

Transfection of Trypanosoma cruzi with host CD40 ligand results in improved control of parasite infection

21 January 2018

1 reference

Human clinical trials of plasmid DNA vaccines

21 January 2018

1 reference

Rational design of gene-based vaccines

21 January 2018

1 reference

Approaches for the design and evaluation of HIV-1 DNA vaccines

21 January 2018

1 reference

DNA vaccines: improving expression of antigens

21 January 2018

1 reference

Progress in DNA-based heterologous prime-boost immunization strategies for malaria

21 January 2018

1 reference

Jump-starting the immune system: prime-boosting comes of age.

21 January 2018

1 reference

The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses

21 January 2018

1 reference

Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control Trypanosoma cruzi infection

21 January 2018

1 reference

In vivo kinetics and biodistribution of a HIV-1 DNA vaccine after administration in mice.

21 January 2018

1 reference

Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle

21 January 2018

1 reference

The injection of plasmid DNA in mouse muscle results in lifelong persistence of DNA, gene expression, and humoral response.

21 January 2018

1 reference

Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice

21 January 2018

1 reference

Parasite-induced chronic inflammation is not exacerbated by immunotherapy before or during Trypanosoma cruzi Infection

21 January 2018

1 reference

Cross-priming of long lived protective CD8+ T cells against Trypanosoma cruzi infection: importance of a TLR9 agonist and CD4+ T cells.

21 January 2018

1 reference

Regulated on activation, normal T cell expressed and secreted (RANTES) antagonist (Met-RANTES) controls the early phase of Trypanosoma cruzi-elicited myocarditis

21 January 2018

1 reference

Interleukin-10 anti-inflammatory response to Borrelia burgdorferi, the agent of Lyme disease: a possible role for suppressors of cytokine signaling 1 and 3.

21 January 2018

1 reference

IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression

21 January 2018

1 reference

Use of proteoliposome as a vaccine against Trypanosoma cruzi in mice.

21 January 2018

1 reference

The Genome Sequence of Trypanosoma cruzi, Etiologic Agent of Chagas Disease

21 January 2018

1 reference

The Trypanosoma cruzi proteome.

21 January 2018

1 reference

Humoral and cellular immune responses in BALB/c and C57BL/6 mice immunized with cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens, in acute experimental Trypanosoma cruzi infection

21 January 2018

1 reference

Comparative evaluation of therapeutic DNA vaccines againstTrypanosoma cruziin mice

21 January 2018

1 reference

Control of Trypanosoma cruzi infection and changes in T-cell populations induced by a therapeutic DNA vaccine in mice

21 January 2018

1 reference

A DNA vaccine encoding CCL4/MIP-1β enhances myocarditis in experimental Trypanosoma cruzi infection in rats

21 January 2018

1 reference

Identity of the major cysteine proteinase (cruzipain) from Trypanosoma cruzi and an antigen (Ag163B6) isolated with a monoclonal antibody

21 January 2018

1 reference

During acute Trypanosoma cruzi infection highly susceptible mice deficient in natural killer cells are protected by a single alpha-galactosylceramide treatment

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.09.45

1 reference

20 August 2017

1 reference

PubMed ID

19538117